| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.7% | -2.5% | -1.5% | -1.8% | 0.5% | 26% |
| Exchange | Ticker | Price |
|---|---|---|
|
BXPHARMA
Beximco Pharmaceuticals Ltd
ISIN: BD0453BXPH04
Shares Out.:
Shares Outstanding:
446.112M1
Shares Float:
431.766M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
114.80 BDT | |
|
BXP
Beximco Pharmaceuticals Ltd DR
ISIN: US0885792061
|
43 GBX |
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
|
DSE: SQURPHARMA
|
$1.54B
270%
189.43B BDT
|
7.3
|
|
|
DSE: RENATA
|
$389.85M
-6.6%
47.82B BDT
|
18.9
|
|
|
DSE: UNILEVERCL
|
$326.4M
-22%
40.03B BDT
|
55.4
|
|
|
DSE: BEACONPHAR
|
$194.17M
-53%
23.82B BDT
|
19.2
|
|
|
DSE: ACI
|
$145.51M
-65%
17.85B BDT
|
154.3
|
|
|
DSE: ACMELAB
|
$130.77M
-69%
16.04B BDT
|
6.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
|
NYSE: LLY
|
$761.68B
182K%
|
38.1
|
|
|
NYSE: JNJ
|
$547.28B
131K%
|
26.4
|
|
|
NYSE: ABBV
|
$360.63B
86K%
|
97.4
|
|
|
SIX: RO
|
$324.68B
78K%
256.25B CHF
|
19.9
|
|
|
LSE: AZN
|
$289.43B
69K%
215.59B GBP
|
27.6
|
|
|
SIX: NOVN
|
$277.35B
66K%
218.9B CHF
|
20.5
|